when will eli lilly release retatrutide Seeking Differentiation Through a Triple Mechanism" Lilly's Again Proves Efficacy in Trials, Raising Question of Whether It Can Overcome Side-Effect Limits and Reshape the Market Eli Lilly infiltrates anti-obesity market

Novo Nordisk has announced a $1.05B investment to expand its manufacturing site in Montes Claros, Brazil, one of the largest pharma investments in the countrys history

PlexusDx explains the clinical evidence, potential interactions, and personalized approaches to combining these therapies

GLP-1 agonists do more than support weight lossemerging clinical evidence shows they can meaningfully reduce blood pressure in patients with hypertension

India today has over 100 million people living with diabetes and nearly 250 million affected by obesity, positioning the country among the largest potential markets for metabolic therapies globally

How to rejuvenate lax, hollow, sensitive, and dehydrated skin